Trial Profile
An open label, parallel,randomised study of denosumab versus Zoledronic acid in post menopausal women treated with Zoledronic acid
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 12 Aug 2016 New trial record